CN108456657B - 犬脐带间充质干细胞及其制备方法和冻存方法 - Google Patents
犬脐带间充质干细胞及其制备方法和冻存方法 Download PDFInfo
- Publication number
- CN108456657B CN108456657B CN201810278145.6A CN201810278145A CN108456657B CN 108456657 B CN108456657 B CN 108456657B CN 201810278145 A CN201810278145 A CN 201810278145A CN 108456657 B CN108456657 B CN 108456657B
- Authority
- CN
- China
- Prior art keywords
- umbilical cord
- mesenchymal stem
- cells
- stem cells
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
Abstract
Description
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810278145.6A CN108456657B (zh) | 2018-03-31 | 2018-03-31 | 犬脐带间充质干细胞及其制备方法和冻存方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810278145.6A CN108456657B (zh) | 2018-03-31 | 2018-03-31 | 犬脐带间充质干细胞及其制备方法和冻存方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108456657A CN108456657A (zh) | 2018-08-28 |
CN108456657B true CN108456657B (zh) | 2020-08-18 |
Family
ID=63237850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810278145.6A Active CN108456657B (zh) | 2018-03-31 | 2018-03-31 | 犬脐带间充质干细胞及其制备方法和冻存方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108456657B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108795853B (zh) * | 2018-05-28 | 2021-08-24 | 天津博雅秀岩生物技术有限公司 | 制备犬胎膜间充质干细胞的方法和犬胎膜间充质干细胞 |
CN108728408B (zh) * | 2018-05-28 | 2021-08-24 | 天津博雅秀岩生物技术有限公司 | 犬胎膜间充质干细胞及制备方法和使用的培养基 |
CN109362708A (zh) * | 2018-11-15 | 2019-02-22 | 广州南医大生物工程有限公司 | 一种干细胞冷冻剂及其应用 |
CN110317782B (zh) * | 2019-07-18 | 2023-06-13 | 天津瑞博斯生物技术有限公司 | 提高间充质干细胞复苏后存活的方法和所用的冻存液 |
CN110317781B (zh) * | 2019-07-18 | 2023-04-21 | 天津瑞博斯生物技术有限公司 | 间充质干细胞冻存和复苏的方法 |
CN112481202B (zh) * | 2020-11-30 | 2022-11-15 | 深圳博雅感知药业有限公司 | 血小板裂解物无血清分离培养脐带间充质干细胞的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101138091B1 (ko) * | 2011-08-31 | 2012-04-24 | 세원셀론텍(주) | 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제 |
CN102660501A (zh) * | 2012-05-21 | 2012-09-12 | 博雅干细胞科技有限公司 | 分离和扩增脐带新鲜组织间充质干细胞的方法 |
KR101733137B1 (ko) * | 2015-12-30 | 2017-05-08 | (주)엑셀세라퓨틱스 | 연골조직 제조를 위한 3차원 오가노이드 블록 제작 방법 |
CN105532650B (zh) * | 2016-03-10 | 2018-01-30 | 广州赛莱拉干细胞科技股份有限公司 | 一种细胞冻存液 |
CN106702499A (zh) * | 2017-01-13 | 2017-05-24 | 天津百恩生物科技有限公司 | 犬科动物间充质干细胞库及其构建方法 |
CN107164319B (zh) * | 2017-05-25 | 2021-06-01 | 佛山科学技术学院 | 一种原代培养犬脐带来源的间充质干细胞的方法 |
CN107384857B (zh) * | 2017-08-02 | 2020-07-31 | 广州中科博雅干细胞科技有限公司 | 自体脂肪间充质干细胞的培养方法和使用的培养基 |
-
2018
- 2018-03-31 CN CN201810278145.6A patent/CN108456657B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108456657A (zh) | 2018-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108456657B (zh) | 犬脐带间充质干细胞及其制备方法和冻存方法 | |
CN108486050B (zh) | 从犬的脐带制备间充质干细胞的方法 | |
Oehme et al. | Cell-based therapies used to treat lumbar degenerative disc disease: a systematic review of animal studies and human clinical trials | |
CN101748096B (zh) | 亚全能干细胞、其制备方法及其用途 | |
CN102660497B (zh) | 脐带组织冻存、复苏以及分离和扩增干细胞的方法 | |
EP1788079A1 (en) | Animal tissue-eccentrically located pluripotent cell proliferating selectively in low-serium medium | |
CN102807966B (zh) | 胎盘全细胞冻存、复苏以及分离和扩增干细胞的方法 | |
CN107299082B (zh) | 从组织中分离胎盘间质细胞并培养成间充质干细胞的方法 | |
CN103667187B (zh) | 一种人脂肪干细胞的分离培养方法和干细胞库的构建方法 | |
CN106465710B (zh) | 脂肪组织冻存液及脂肪组织冻存方法 | |
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
CN103074298B (zh) | 一种人脂肪间充质干细胞库及其构建方法 | |
CN102660501A (zh) | 分离和扩增脐带新鲜组织间充质干细胞的方法 | |
CN104673745A (zh) | 一种猪脂肪干细胞的分离培养方法 | |
CN108728408B (zh) | 犬胎膜间充质干细胞及制备方法和使用的培养基 | |
CN110317782B (zh) | 提高间充质干细胞复苏后存活的方法和所用的冻存液 | |
CN110317781B (zh) | 间充质干细胞冻存和复苏的方法 | |
CN102367435A (zh) | 人富血小板血浆的制备及在人间充质干细胞分离培养中的应用 | |
CN110938590B (zh) | 一种间充质干细胞无血清培养基及其用途 | |
CN108103009A (zh) | 一种胎盘间充质干细胞的制备方法 | |
CN109735490A (zh) | 一种脂肪干细胞提取方法 | |
Mohammadi-Sangcheshmeh et al. | Isolation, characterization, and mesodermic differentiation of stem cells from adipose tissue of camel (Camelus dromedarius) | |
Romanov et al. | Optimized protocol for isolation of multipotent mesenchymal stromal cells from human umbilical cord | |
CN109628388B (zh) | 用消化酶组合物从胎盘血管分离间充质干细胞 | |
CN106614524B (zh) | 一种间充质干细胞的保存液以及保存方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180906 Address after: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Applicant after: Tianjin Boya Xiu Yan Biotechnology Co., Ltd. Applicant after: Weihai North Boya Species Diversity Research Institute Co., Ltd. Address before: 214092 Boya, 88 Mashang Road, Mashan, Wuxi, Jiangsu Applicant before: Wuxi Boya Gene Technology Co., Ltd. Applicant before: Intco Boya (Tianjin) Co., Ltd. gene technology Applicant before: Weihai North Boya Species Diversity Research Institute Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190912 Address after: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Applicant after: Tianjin Boya Xiu Yan Biotechnology Co., Ltd. Address before: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Applicant before: Tianjin Boya Xiu Yan Biotechnology Co., Ltd. Applicant before: Weihai North Boya Species Diversity Research Institute Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 300457 building a, Alexandria, No. 3, Haitong street, Binhai New Area Development Zone, Tianjin Patentee after: Tianjin ruibosi Biotechnology Co.,Ltd. Address before: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Patentee before: TIANJIN BOYALIFE BIOTECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address |